Cancers of Unknown Primary
📧 Sign up to get email alerts when something new happens for Cancers of Unknown Primary.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: Ceritinib (LDK378) for Patients Whose Tumors Have Aberrations in ALK or ROS1 (SIGNATURE) [Phase 2]
Phase 2 trial update for ceritinib in tumors with ALK or ROS1 aberrations; study terminated with results posted.